The organizers of the Annual Partnerships in Clinical Trials and Central Labs events are pleased to introduce you to Advanced Biomarker Strategies in Oncology Drug Development. This unique clinical immersion program is the first of our three part Target Clinical Trials Series, delivering therapeutic-specific strategies to facilitate the execution of successful clinical trials. The 2010 oncology series begins February 4-5, 2010 at Grand Hyatt San Francisco with a two-day program focusing exclusively on the latest development in oncology biomarkers.
This invitation only think tank is FREE to biopharma VP and Director level clinical research executives and brings together 75-100 leaders in clinical R&D, oncology, drug development, and translational research in an exciting and engaging environment to deliver and develop solutions, industry standards and practical applications for biomarker development and validation.
For more information, visit the website here:
http://bit.ly/8fqv8m
Connect with your Oncology Clinical Trial peers when you join the Target Clinical Series LinkedIn group:
http://bit.ly/8gZtsd
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment